All Blogs

Oct 03, 2017

Therapeutics and Celgene to develop therapies; Takeda’s expansion; J&J hopes to limit; Tech Prize for genome sequencing; Endocyte’s late-stage prostate cancer deal


Sep 28, 2017

Alzeimer’s drug; Guardant Health receives approval; First Patient Dosed in Phase 1 Clinical Trial; Sunny Pharmtech and Vitruvias Therapeutics Receive FDA Approval


Sep 22, 2017

Isocitrate dehydrogenase (IDH) inhibitors– Emerging Anti-Cancer Therapeutics


Sep 20, 2017

Business Cocktail


Sep 19, 2017

Thrombolytic Sciences’ trial; NurOwn for ALS; Biosimilar receives approval; Trelegy Ellipta for the treatment of COPD


Sep 18, 2017

Oral Mucositis – A Common Cancer Therapy Adverse Reaction


Sep 15, 2017

Human Papillomavirus (HPV) Prophylaxis– Expected to see a steady growth from 2015-2025


Sep 15, 2017

Business cocktail


Sep 13, 2017

South Korean researchers influencing lift of human-embryo restrictions


Sep 12, 2017

Idera’s Phase I Data; DelMar Initiates Trial; Novartis’ study; Humira gets EC approval